A detailed history of Beacon Pointe Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 3,491 shares of NTRA stock, worth $566,903. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,491
Previous 3,776 7.55%
Holding current value
$566,903
Previous $408,000 8.58%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $27,858 - $36,955
-285 Reduced 7.55%
3,491 $443,000
Q2 2024

Aug 12, 2024

BUY
$85.28 - $112.6 $126,896 - $167,548
1,488 Added 65.03%
3,776 $408,000
Q1 2024

May 14, 2024

BUY
$59.21 - $92.9 $135,472 - $212,555
2,288 New
2,288 $209,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.